<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10000">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00702377</url>
  </required_header>
  <id_info>
    <org_study_id>C-07-33</org_study_id>
    <nct_id>NCT00702377</nct_id>
  </id_info>
  <brief_title>Evaluation of SYSTANE Ultra Lubricant Eye Drops</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of two artificial tears in dry eye patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Tear Break-up Time</measure>
    <time_frame>Day 0, Day 7, Day 14, Day 28, and Day 42</time_frame>
    <safety_issue>No</safety_issue>
    <description>Tear breakup time is the time interval between a blink and the development of a dry spot in the tear film. Less than 10 seconds is abnormal. Dry spot is visible after fluorescein staining when viewed under a slit-lamp.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctival Staining</measure>
    <time_frame>Day 0, Day 7, Day 14, Day 28, Day 42</time_frame>
    <safety_issue>No</safety_issue>
    <description>Conjunctival staining refers to the appearance of spots on the conjunctiva when dyed with lissamine green stain during an eye examination. Lissamine green temporarily stains the surface of the conjunctiva of the eye. An eye doctor looking at the eye's surface through a slit lamp observes the spots as green spots. Conjunctival staining grading scale is a 6 point scale, with 0 equals no staining (best case) and 6 equals maximum (worst) staining.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal Staining</measure>
    <time_frame>Day 0, Day 7, Day 14, Day 28, Day 42</time_frame>
    <safety_issue>No</safety_issue>
    <description>Corneal staining refers to the appearance of corneal abrasions when dyed with fluorescein drops during an eye examination. Fluorescein temporarily stains the surface of the cornea of the eye. An eye doctor looking at the eye's surface through a slit lamp observes the abrasions as brightly-colored spots on an otherwise smooth cornea. Corneal staining grading scale is a 15 point scale, with 0 equals no staining (best case) and 15 equals maximum (worst) staining.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">109</enrollment>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>SYSTANE Ultra</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SYSTANE Ultra Lubricant Eye Drops</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OPTIVE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>OPTIVE Lubricant Eye Drops</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SYSTANE Ultra</intervention_name>
    <description>SYSTANE Ultra Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
    <arm_group_label>SYSTANE Ultra</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optive</intervention_name>
    <description>Optive Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
    <arm_group_label>OPTIVE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented diagnosis of dry eyes

          -  Must not have worn contact lenses for 1 week preceding enrollment

        Exclusion Criteria:

          -  Age related
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Contact Call Center for Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <lastchanged_date>January 31, 2012</lastchanged_date>
  <firstreceived_date>June 19, 2008</firstreceived_date>
  <firstreceived_results_date>September 23, 2009</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>109 dry eye subjects</recruitment_details>
      <pre_assignment_details>Randomized, double-masked, parallel design</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>SYSTANE Ultra</title>
          <description>SYSTANE Ultra Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
        </group>
        <group group_id="P2">
          <title>OPTIVE Lubricant Eye Drops</title>
          <description>OPTIVE Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
                <participants group_id="P2" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>SYSTANE Ultra</title>
          <description>SYSTANE Ultra Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
        </group>
        <group group_id="B2">
          <title>OPTIVE Lubricant Eye Drops</title>
          <description>OPTIVE Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="53"/>
                <measurement group_id="B2" value="56"/>
                <measurement group_id="B3" value="109"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
                <measurement group_id="B2" value="43"/>
                <measurement group_id="B3" value="77"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="19"/>
                <measurement group_id="B2" value="13"/>
                <measurement group_id="B3" value="32"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="39"/>
                <measurement group_id="B2" value="41"/>
                <measurement group_id="B3" value="80"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
                <measurement group_id="B2" value="15"/>
                <measurement group_id="B3" value="29"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Tear Break-up Time</title>
        <description>Tear breakup time is the time interval between a blink and the development of a dry spot in the tear film. Less than 10 seconds is abnormal. Dry spot is visible after fluorescein staining when viewed under a slit-lamp.</description>
        <time_frame>Day 0, Day 7, Day 14, Day 28, and Day 42</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>SYSTANE Ultra</title>
            <description>SYSTANE Ultra Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
          </group>
          <group group_id="O2">
            <title>OPTIVE Lubricant Eye Drops</title>
            <description>OPTIVE Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="53"/>
                  <measurement group_id="O2" value="56"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Tear Break-up Time</title>
            <description>Tear breakup time is the time interval between a blink and the development of a dry spot in the tear film. Less than 10 seconds is abnormal. Dry spot is visible after fluorescein staining when viewed under a slit-lamp.</description>
            <units>seconds</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Day 0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="4.2" spread="1.9"/>
                  <measurement group_id="O2" value="4.5" spread="2.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 7</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="4.7" spread="2.8"/>
                  <measurement group_id="O2" value="4.2" spread="1.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 14</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="4.8" spread="2.8"/>
                  <measurement group_id="O2" value="4.2" spread="1.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 28</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="4.6" spread="2.6"/>
                  <measurement group_id="O2" value="5.2" spread="3.2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 42</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="4.5" spread="2.3"/>
                  <measurement group_id="O2" value="4.2" spread="2.3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Conjunctival Staining</title>
        <description>Conjunctival staining refers to the appearance of spots on the conjunctiva when dyed with lissamine green stain during an eye examination. Lissamine green temporarily stains the surface of the conjunctiva of the eye. An eye doctor looking at the eye’s surface through a slit lamp observes the spots as green spots. Conjunctival staining grading scale is a 6 point scale, with 0 equals no staining (best case) and 6 equals maximum (worst) staining.</description>
        <time_frame>Day 0, Day 7, Day 14, Day 28, Day 42</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>SYSTANE Ultra</title>
            <description>SYSTANE Ultra Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
          </group>
          <group group_id="O2">
            <title>OPTIVE Lubricant Eye Drops</title>
            <description>OPTIVE Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="53"/>
                  <measurement group_id="O2" value="56"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Conjunctival Staining</title>
            <description>Conjunctival staining refers to the appearance of spots on the conjunctiva when dyed with lissamine green stain during an eye examination. Lissamine green temporarily stains the surface of the conjunctiva of the eye. An eye doctor looking at the eye’s surface through a slit lamp observes the spots as green spots. Conjunctival staining grading scale is a 6 point scale, with 0 equals no staining (best case) and 6 equals maximum (worst) staining.</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Day 0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.3" spread="1.1"/>
                  <measurement group_id="O2" value="2.8" spread="1.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 7</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.1"/>
                  <measurement group_id="O2" value="2.5" spread="1.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 14</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.2"/>
                  <measurement group_id="O2" value="2.2" spread="1.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 28</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.1"/>
                  <measurement group_id="O2" value="2.4" spread="1.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 42</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.0"/>
                  <measurement group_id="O2" value="2.7" spread="1.4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Corneal Staining</title>
        <description>Corneal staining refers to the appearance of corneal abrasions when dyed with fluorescein drops during an eye examination. Fluorescein temporarily stains the surface of the cornea of the eye. An eye doctor looking at the eye’s surface through a slit lamp observes the abrasions as brightly-colored spots on an otherwise smooth cornea. Corneal staining grading scale is a 15 point scale, with 0 equals no staining (best case) and 15 equals maximum (worst) staining.</description>
        <time_frame>Day 0, Day 7, Day 14, Day 28, Day 42</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>SYSTANE Ultra</title>
            <description>SYSTANE Ultra Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
          </group>
          <group group_id="O2">
            <title>OPTIVE Lubricant Eye Drops</title>
            <description>OPTIVE Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="53"/>
                  <measurement group_id="O2" value="56"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Corneal Staining</title>
            <description>Corneal staining refers to the appearance of corneal abrasions when dyed with fluorescein drops during an eye examination. Fluorescein temporarily stains the surface of the cornea of the eye. An eye doctor looking at the eye’s surface through a slit lamp observes the abrasions as brightly-colored spots on an otherwise smooth cornea. Corneal staining grading scale is a 15 point scale, with 0 equals no staining (best case) and 15 equals maximum (worst) staining.</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Day 0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="4.8" spread="1.8"/>
                  <measurement group_id="O2" value="5.3" spread="2.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 7</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.6" spread="2.2"/>
                  <measurement group_id="O2" value="4.3" spread="3.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 14</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.9" spread="2.1"/>
                  <measurement group_id="O2" value="4.5" spread="2.9"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 28</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.1" spread="2.1"/>
                  <measurement group_id="O2" value="3.8" spread="2.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Day 42</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.9" spread="1.8"/>
                  <measurement group_id="O2" value="4.2" spread="2.8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From Day 0 to Day 42.</time_frame>
      <desc>Adverse events were both volunteered and solicited.</desc>
      <group_list>
        <group group_id="E1">
          <title>SYSTANE Ultra</title>
          <description>SYSTANE Ultra Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
        </group>
        <group group_id="E2">
          <title>OPTIVE Lubricant Eye Drops</title>
          <description>OPTIVE Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 11.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI should hold confidential, and not disclose directly or indirectly to any third party other than Contractors, the data arising out of the study. Alcon reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alcon Clinical</name_or_title>
      <organization>Alcon Research Ltd</organization>
      <phone>888.451.3937; 817.568.6725</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
